13-F holdings, Q3 2026
Capricorn Fund Managers Ltd
A 13-F is the report large US investment managers file with the SEC each quarter, listing the stocks they held at quarter end.
- Reported value
- $1.1B
- Positions
- 130
- Filed
- Data as of
These holdings are as of , 44 days ago.
13-Fs for Q4 2026 are due by .
See this manager's Holder IQ and how the book overlaps yours
Free to start, with no card. Holder IQ scores a manager's past record. It describes the past and is not a recommendation to buy or sell anything. Sign up and you can follow this manager: one notice for each new 13-F, naming what changed and which of those positions you hold or watch.
Top holdings
- SHEL$38M400,000 shares3.6% of the book
- MSFT$33.6M65,520 shares3.2% of the book
- LNC$33M820,000 shares3.1% of the book
- CVNA$32.7M523,120 shares3.1% of the book
- BAC$27.9M512,500 shares2.6% of the book
- LPLA$26.8M87,551 shares2.5% of the book
- C$26.5M205,000 shares2.5% of the book
- XENE$21.2M568,800 shares2% of the book
- TSM$20.2M44,200 shares1.9% of the book
- ROIV$19.7M537,409 shares1.9% of the book
What changed this quarter
42 new positions and 79 sold out, against Q2 2026. Added and trimmed positions use the change in split-adjusted shares at the Q3 2026 implied price; full exits use their Q2 2026 reported value, not sale proceeds.
Largest buys
- LNC
Lincoln National Corp
+$33M
New
Your stake and evidence for LNC
What it means for you
This public view does not read your holdings or watchlist; open the member view to check your stake.
Use this to decide what to research, rather than as an instruction to copy a trade.
What happened
A position newly appears in the Q3 2026 book.
Displayed change: +$33M. The current book reports 820,000 shares.
Why it can matter
A change between quarter-end disclosures can prompt a question about the manager's exposure. It does not reveal the trade date, the execution price or why the position changed; a full exit is not proof of a bearish decision.
How we got this
A new position uses its current quarter's reported dollar value; this is not the amount spent buying it.
Comparable books exclude identified CUSIP, share-basis and new-security events from trades. Exit-size bands describe prior book weight, not the manager's intent.
Where the data comes from
SEC 13F quarter-end holdings for Q2 2026 and Q3 2026; these delayed disclosures omit shorts and many other assets.
Current source filed .
Technical details
Reported dollar change: 33013200 USD. Current reported shares: 820000. Prior shares on current basis: not recorded.
- C
Citigroup
+$26.5M
New
Your stake and evidence for C
What it means for you
This public view does not read your holdings or watchlist; open the member view to check your stake.
Use this to decide what to research, rather than as an instruction to copy a trade.
What happened
A position newly appears in the Q3 2026 book.
Displayed change: +$26.5M. The current book reports 205,000 shares.
Why it can matter
A change between quarter-end disclosures can prompt a question about the manager's exposure. It does not reveal the trade date, the execution price or why the position changed; a full exit is not proof of a bearish decision.
How we got this
A new position uses its current quarter's reported dollar value; this is not the amount spent buying it.
Comparable books exclude identified CUSIP, share-basis and new-security events from trades. Exit-size bands describe prior book weight, not the manager's intent.
Where the data comes from
SEC 13F quarter-end holdings for Q2 2026 and Q3 2026; these delayed disclosures omit shorts and many other assets.
Current source filed .
Technical details
Reported dollar change: 26543400 USD. Current reported shares: 205000. Prior shares on current basis: not recorded.
- XENE
Xenon Pharmaceuticals
+$20.4M
+2,621.5% shares
Your stake and evidence for XENE
What it means for you
This public view does not read your holdings or watchlist; open the member view to check your stake.
Use this to decide what to research, rather than as an instruction to copy a trade.
What happened
Reported shares increased between Q2 2026 and Q3 2026.
Displayed change: +$20.4M. The current book reports 568,800 shares.
Why it can matter
A change between quarter-end disclosures can prompt a question about the manager's exposure. It does not reveal the trade date, the execution price or why the position changed; a full exit is not proof of a bearish decision.
How we got this
For an added or trimmed position, subtract split-adjusted prior shares from current shares, then multiply by the current book's reported value per share; this is not the execution price.
568,800 current shares − 20,900 prior shares on the same basis = +547,900 shares.
Comparable books exclude identified CUSIP, share-basis and new-security events from trades. Exit-size bands describe prior book weight, not the manager's intent.
Where the data comes from
SEC 13F quarter-end holdings for Q2 2026 and Q3 2026; these delayed disclosures omit shorts and many other assets.
Current source filed .
Technical details
Reported dollar change: 20376401 USD. Current reported shares: 568800. Prior shares on current basis: 20900.
- ROIV
Roivant Sciences Ltd
+$18.2M
+1,240.2% shares
Your stake and evidence for ROIV
What it means for you
This public view does not read your holdings or watchlist; open the member view to check your stake.
Use this to decide what to research, rather than as an instruction to copy a trade.
What happened
Reported shares increased between Q2 2026 and Q3 2026.
Displayed change: +$18.2M. The current book reports 537,409 shares.
Why it can matter
A change between quarter-end disclosures can prompt a question about the manager's exposure. It does not reveal the trade date, the execution price or why the position changed; a full exit is not proof of a bearish decision.
How we got this
For an added or trimmed position, subtract split-adjusted prior shares from current shares, then multiply by the current book's reported value per share; this is not the execution price.
537,409 current shares − 40,100 prior shares on the same basis = +497,309 shares.
Comparable books exclude identified CUSIP, share-basis and new-security events from trades. Exit-size bands describe prior book weight, not the manager's intent.
Where the data comes from
SEC 13F quarter-end holdings for Q2 2026 and Q3 2026; these delayed disclosures omit shorts and many other assets.
Current source filed .
Technical details
Reported dollar change: 18186590.009700246 USD. Current reported shares: 537409. Prior shares on current basis: 40100.
- CPAY
CORPAY INC
+$17.1M
New
Your stake and evidence for CPAY
What it means for you
This public view does not read your holdings or watchlist; open the member view to check your stake.
Use this to decide what to research, rather than as an instruction to copy a trade.
What happened
A position newly appears in the Q3 2026 book.
Displayed change: +$17.1M. The current book reports 44,000 shares.
Why it can matter
A change between quarter-end disclosures can prompt a question about the manager's exposure. It does not reveal the trade date, the execution price or why the position changed; a full exit is not proof of a bearish decision.
How we got this
A new position uses its current quarter's reported dollar value; this is not the amount spent buying it.
Comparable books exclude identified CUSIP, share-basis and new-security events from trades. Exit-size bands describe prior book weight, not the manager's intent.
Where the data comes from
SEC 13F quarter-end holdings for Q2 2026 and Q3 2026; these delayed disclosures omit shorts and many other assets.
Current source filed .
Technical details
Reported dollar change: 17098400 USD. Current reported shares: 44000. Prior shares on current basis: not recorded.
Largest sells
- KKR
KKR & Co
−$40.1M
-95.4% shares
Your stake and evidence for KKR
What it means for you
This public view does not read your holdings or watchlist; open the member view to check your stake.
Use this to decide what to research, rather than as an instruction to copy a trade.
What happened
Reported shares decreased between Q2 2026 and Q3 2026.
Displayed change: −$40.1M. The current book reports 21,300 shares.
Why it can matter
A change between quarter-end disclosures can prompt a question about the manager's exposure. It does not reveal the trade date, the execution price or why the position changed; a full exit is not proof of a bearish decision.
How we got this
For an added or trimmed position, subtract split-adjusted prior shares from current shares, then multiply by the current book's reported value per share; this is not the execution price.
21,300 current shares − 460,100 prior shares on the same basis = -438,800 shares.
Comparable books exclude identified CUSIP, share-basis and new-security events from trades. Exit-size bands describe prior book weight, not the manager's intent.
Where the data comes from
SEC 13F quarter-end holdings for Q2 2026 and Q3 2026; these delayed disclosures omit shorts and many other assets.
Current source filed .
Technical details
Reported dollar change: -40062440 USD. Current reported shares: 21300. Prior shares on current basis: 460100.
- BP
BP plc
−$36.7M
-84.8% shares
Your stake and evidence for BP
What it means for you
This public view does not read your holdings or watchlist; open the member view to check your stake.
Use this to decide what to research, rather than as an instruction to copy a trade.
What happened
Reported shares decreased between Q2 2026 and Q3 2026.
Displayed change: −$36.7M. The current book reports 150,000 shares.
Why it can matter
A change between quarter-end disclosures can prompt a question about the manager's exposure. It does not reveal the trade date, the execution price or why the position changed; a full exit is not proof of a bearish decision.
How we got this
For an added or trimmed position, subtract split-adjusted prior shares from current shares, then multiply by the current book's reported value per share; this is not the execution price.
150,000 current shares − 984,203 prior shares on the same basis = -834,203 shares.
Comparable books exclude identified CUSIP, share-basis and new-security events from trades. Exit-size bands describe prior book weight, not the manager's intent.
Where the data comes from
SEC 13F quarter-end holdings for Q2 2026 and Q3 2026; these delayed disclosures omit shorts and many other assets.
Current source filed .
Technical details
Reported dollar change: -36696589.97 USD. Current reported shares: 150000. Prior shares on current basis: 984203.
- LPLA
LPL Financial Holdings
−$32.8M
-55.1% shares
Your stake and evidence for LPLA
What it means for you
This public view does not read your holdings or watchlist; open the member view to check your stake.
Use this to decide what to research, rather than as an instruction to copy a trade.
What happened
Reported shares decreased between Q2 2026 and Q3 2026.
Displayed change: −$32.8M. The current book reports 87,551 shares.
Why it can matter
A change between quarter-end disclosures can prompt a question about the manager's exposure. It does not reveal the trade date, the execution price or why the position changed; a full exit is not proof of a bearish decision.
How we got this
For an added or trimmed position, subtract split-adjusted prior shares from current shares, then multiply by the current book's reported value per share; this is not the execution price.
87,551 current shares − 194,812 prior shares on the same basis = -107,261 shares.
Comparable books exclude identified CUSIP, share-basis and new-security events from trades. Exit-size bands describe prior book weight, not the manager's intent.
Where the data comes from
SEC 13F quarter-end holdings for Q2 2026 and Q3 2026; these delayed disclosures omit shorts and many other assets.
Current source filed .
Technical details
Reported dollar change: -32800414.045025185 USD. Current reported shares: 87551. Prior shares on current basis: 194812.
- APP
Applovin Corp
−$31.6M
Sold out, was 2.5% of the book
Your stake and evidence for APP
What it means for you
This public view does not read your holdings or watchlist; open the member view to check your stake.
Use this to decide what to research, rather than as an instruction to copy a trade.
What happened
The position reported in Q2 2026 is absent from the comparable Q3 2026 book.
Displayed change: −$31.6M. This was 2.5% of the prior book.
Why it can matter
A change between quarter-end disclosures can prompt a question about the manager's exposure. It does not reveal the trade date, the execution price or why the position changed; a full exit is not proof of a bearish decision.
How we got this
A full exit is shown as the negative of its prior reported value, not sale proceeds or a value at today's price.
Comparable books exclude identified CUSIP, share-basis and new-security events from trades. Exit-size bands describe prior book weight, not the manager's intent.
Where the data comes from
SEC 13F quarter-end holdings for Q2 2026 and Q3 2026; these delayed disclosures omit shorts and many other assets.
Current source filed .
Technical details
Reported dollar change: -31571233 USD. Current reported shares: not recorded. Prior shares on current basis: 61276.
- ING
ING Groep NV
−$28.2M
Sold out, was 2.3% of the book
Your stake and evidence for ING
What it means for you
This public view does not read your holdings or watchlist; open the member view to check your stake.
Use this to decide what to research, rather than as an instruction to copy a trade.
What happened
The position reported in Q2 2026 is absent from the comparable Q3 2026 book.
Displayed change: −$28.2M. This was 2.3% of the prior book.
Why it can matter
A change between quarter-end disclosures can prompt a question about the manager's exposure. It does not reveal the trade date, the execution price or why the position changed; a full exit is not proof of a bearish decision.
How we got this
A full exit is shown as the negative of its prior reported value, not sale proceeds or a value at today's price.
Comparable books exclude identified CUSIP, share-basis and new-security events from trades. Exit-size bands describe prior book weight, not the manager's intent.
Where the data comes from
SEC 13F quarter-end holdings for Q2 2026 and Q3 2026; these delayed disclosures omit shorts and many other assets.
Current source filed .
Technical details
Reported dollar change: -28242000 USD. Current reported shares: not recorded. Prior shares on current basis: 900000.
What was sold out, by size
- 36 real positions, 0.25% of the book or more
- 42 small, between 0.015% and 0.25%
- 1 slivers under 0.015%, often rounding or client flows
Not counted as trades: SKIN (new CUSIP), ADPT (share-count change), SPGI (share-count change), UROY (new CUSIP).
All of this comes from the filer's public SEC filings. A 13-F shows long positions in US-listed securities at quarter end and can leave out short positions, cash and non-US holdings, so it is not the whole portfolio. This is filing data, not investment advice.